Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Isbister

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Blut|February 1, 1984
CFU-C inhibitors in aplastic anaemiaT C Morris, P C Vincent, G A Young, et al.
Australian and New Zealand Journal of Medicine|June 1, 1986
IgA kappa multiple myeloma and lymphadenopathy syndrome associated with AIDS virus infectionM A Thomas, L S Ibels, J V Wells, et al.
Anaesthesia and Intensive Care|February 1, 1983
A rational approach to crossmatching blood for elective surgeryA J Dodds, A Pun, J P Isbister, et al.
Australian and New Zealand Journal of Medicine|August 1, 1985
Heparin-associated acute adrenal insufficiencyC K Arthur, S J Grant, W K Murray, et al.
Vox Sanguinis|February 10, 2017
Descriptive characteristics and in-hospital mortality of critically bleeding patients requiring massive transfusion: results from the Australian and New Zealand Massive Transfusion RegistryR Ruseckaite, Z K McQuilten, J C Oldroyd, et al.
Clinical and Laboratory Haematology|January 1, 1989
CFU-GM inhibitors in neutropeniaT C Morris, P C Vincent, G A Young, et al.
Vox Sanguinis|August 6, 2014
What factors contribute to hospital variation in obstetric transfusion rates?J A Patterson, C L Roberts, J P Isbister, et al.
Lancet (London, England)|January 17, 1987
Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemiaD D Ma, R D Scurr, R A Davey, et al.
BMC Research Notes|October 8, 2016
Improving outcomes for hospital patients with critical bleeding requiring massive transfusion: the Australian and New Zealand Massive Transfusion Registry study methodologyJ C Oldroyd, K M Venardos, N J Aoki, et al.
Vox Sanguinis|April 5, 2014
Elucidating the clinical characteristics of patients captured using different definitions of massive transfusionA J Zatta, Z K McQuilten, B Mitra, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Blut|February 1, 1984
CFU-C inhibitors in aplastic anaemiaT C Morris, P C Vincent, G A Young, et al.
Australian and New Zealand Journal of Medicine|June 1, 1986
IgA kappa multiple myeloma and lymphadenopathy syndrome associated with AIDS virus infectionM A Thomas, L S Ibels, J V Wells, et al.
Anaesthesia and Intensive Care|February 1, 1983
A rational approach to crossmatching blood for elective surgeryA J Dodds, A Pun, J P Isbister, et al.
Australian and New Zealand Journal of Medicine|August 1, 1985
Heparin-associated acute adrenal insufficiencyC K Arthur, S J Grant, W K Murray, et al.
Vox Sanguinis|February 10, 2017
Descriptive characteristics and in-hospital mortality of critically bleeding patients requiring massive transfusion: results from the Australian and New Zealand Massive Transfusion RegistryR Ruseckaite, Z K McQuilten, J C Oldroyd, et al.
Clinical and Laboratory Haematology|January 1, 1989
CFU-GM inhibitors in neutropeniaT C Morris, P C Vincent, G A Young, et al.
Vox Sanguinis|August 6, 2014
What factors contribute to hospital variation in obstetric transfusion rates?J A Patterson, C L Roberts, J P Isbister, et al.
Lancet (London, England)|January 17, 1987
Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemiaD D Ma, R D Scurr, R A Davey, et al.
BMC Research Notes|October 8, 2016
Improving outcomes for hospital patients with critical bleeding requiring massive transfusion: the Australian and New Zealand Massive Transfusion Registry study methodologyJ C Oldroyd, K M Venardos, N J Aoki, et al.
Vox Sanguinis|April 5, 2014
Elucidating the clinical characteristics of patients captured using different definitions of massive transfusionA J Zatta, Z K McQuilten, B Mitra, et al.
Pageof 9